Locations:
Search
Findings support emphasis on markers of frailty related to, but not dependent on, age
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Additional analyses of the two trials presented at 2023 ESC Congress
But findings apply only to middle-aged or older men with confirmed hypogonadism
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Findings hold implications for screening and potential nonsurgical therapy
Potential benefits include clinical guidance, TAVR outcome prediction, device testing
Network proximity and EHR analyses identify diabetes drug as a top candidate for risk reduction
Sophisticated in vivo modeling can enhance device development and therapy testing
DT-MRI and RNA-FISH show increase in CITED4 promotes healthy architecture of myocardium
Prospective SPIRIT-HCM trial demonstrates broad gains over 12-month follow-up
Advertisement
Advertisement